Article
Genotype-Guided vs Conventional Oral P2Y12 Inhibitors in Acute Coronary Syndrome: A Combined Analysis of TAILOR-PCI and POPular Genetics.
JACC. Cardiovascular interventions - 9 Feb 2026
Galli Mattia, Pereira Naveen L, Lennon Ryan J, van den Broek Wout W A, Claassens Daniel M F, Bergmeijer Thomas O, Rosenberg Yves, Fazzini Luca, Deneer Vera H M, Murad M Hassan, Farkouh Michael E, Rihal Charanjit, Ten Berg Jurrien, Angiolillo Dominick J
Abstract excerpt
BACKGROUND: Genotype-guided P2Y12 inhibitor selection may improve outcomes in acute coronary syndrome (ACS) or percutaneous coronary interventions (PCI) patients. OBJECTIVES: This study sought to assess the impact of guided therapy escalation or de-escalation vs conventional therapy. METHODS: Randomized controlled trials comparing guided therapy using CYP2C19 genetic testing vs conventional therapy among patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
